152 related articles for article (PubMed ID: 32995355)
21. Production of Recombinant Rabies Virus Glycoprotein by Insect Cells in a Single-Use Fixed-Bed Bioreactor.
Ventini-Monteiro DC; Astray RM; Pereira CA
Methods Mol Biol; 2018; 1674():87-94. PubMed ID: 28921430
[TBL] [Abstract][Full Text] [Related]
22. Optimization of lentiviral vector production using polyethylenimine-mediated transfection.
Tang Y; Garson K; Li L; Vanderhyden BC
Oncol Lett; 2015 Jan; 9(1):55-62. PubMed ID: 25435933
[TBL] [Abstract][Full Text] [Related]
23. Establishing functional lentiviral vector production in a stirred bioreactor for CAR-T cell therapy.
Tang QL; Gu LX; Xu Y; Liao XH; Zhou Y; Zhang TC
Bioengineered; 2021 Dec; 12(1):2095-2105. PubMed ID: 34047682
[TBL] [Abstract][Full Text] [Related]
24. Development of a high-yield live-virus vaccine production platform using a novel fixed-bed bioreactor.
Berrie DM; Waters RC; Montoya C; Chatel A; Vela EM
Vaccine; 2020 Apr; 38(20):3639-3645. PubMed ID: 32247568
[TBL] [Abstract][Full Text] [Related]
25. Quasi-perfusion studies for intensified lentiviral vector production using a continuous stable producer cell line.
Stibbs DJ; Silva Couto P; Takeuchi Y; Rafiq QA; Jackson NB; Rayat ACME
Mol Ther Methods Clin Dev; 2024 Jun; 32(2):101264. PubMed ID: 38827249
[TBL] [Abstract][Full Text] [Related]
26. Development of a scalable process for high-yield lentiviral vector production by transient transfection of HEK293 suspension cultures.
Ansorge S; Lanthier S; Transfiguracion J; Durocher Y; Henry O; Kamen A
J Gene Med; 2009 Oct; 11(10):868-76. PubMed ID: 19618482
[TBL] [Abstract][Full Text] [Related]
27. Generation of a packaging cell line for prolonged large-scale production of high-titer HIV-1-based lentiviral vector.
Ni Y; Sun S; Oparaocha I; Humeau L; Davis B; Cohen R; Binder G; Chang YN; Slepushkin V; Dropulic B
J Gene Med; 2005 Jun; 7(6):818-34. PubMed ID: 15693055
[TBL] [Abstract][Full Text] [Related]
28. Genetic alteration of SJ293TS cells and modification of serum-free media enhances lentiviral vector production.
Bauler M; Ferrara F; Lowe B; Beard JA; Wincek C; Wielgosz MM; Park JJ; Shang N; Nandy S; Li C; Langfitt DM; Zhou S; Throm RE
Mol Ther Methods Clin Dev; 2024 Jun; 32(2):101270. PubMed ID: 38883976
[TBL] [Abstract][Full Text] [Related]
29. Retroviral vector production using suspension-adapted 293GPG cells in a 3L acoustic filter-based perfusion bioreactor.
Ghani K; Garnier A; Coelho H; Transfiguracion J; Trudel P; Kamen A
Biotechnol Bioeng; 2006 Nov; 95(4):653-60. PubMed ID: 16947907
[TBL] [Abstract][Full Text] [Related]
30. Upstream process optimization and micro- and macrocarrier screening for large-scale production of the oncolytic H-1 protoparvovirus.
Wohlfarth D; Frehtman V; Müller M; Vogel M; Phan LMP; Brunecker A; Leuchs B
Appl Microbiol Biotechnol; 2021 Dec; 105(24):9113-9124. PubMed ID: 34782922
[TBL] [Abstract][Full Text] [Related]
31. Preclinical Proof-of-Concept, Analytical Development, and Commercial Scale Production of Lentiviral Vector in Adherent Cells.
Leinonen HM; Lipponen EM; Valkama AJ; Hynynen H; Oruetxebarria I; Turkki V; Olsson V; Kurkipuro J; Samaranayake H; Määttä AM; Parker NR; Ylä-Herttuala S; Lesch HP
Mol Ther Methods Clin Dev; 2019 Dec; 15():63-71. PubMed ID: 31649956
[TBL] [Abstract][Full Text] [Related]
32. Rational plasmid design and bioprocess optimization to enhance recombinant adeno-associated virus (AAV) productivity in mammalian cells.
Emmerling VV; Pegel A; Milian EG; Venereo-Sanchez A; Kunz M; Wegele J; Kamen AA; Kochanek S; Hoerer M
Biotechnol J; 2016 Feb; 11(2):290-7. PubMed ID: 26284700
[TBL] [Abstract][Full Text] [Related]
33. Modified CelliGen-packed bed bioreactors for hybridoma cell cultures.
Wang G; Zhang W; Jacklin C; Freedman D; Eppstein L; Kadouri A
Cytotechnology; 1992; 9(1-3):41-9. PubMed ID: 1369180
[TBL] [Abstract][Full Text] [Related]
34. Production of rhEPO with a serum-free medium in the packed bed bioreactor.
Deng J; Yang Q; Cheng X; Li L; Zhou J
Chin J Biotechnol; 1997; 13(4):247-52. PubMed ID: 9631260
[TBL] [Abstract][Full Text] [Related]
35. Characterization of lentiviral vector production using microwell suspension cultures of HEK293T-derived producer cells.
Guy HM; McCloskey L; Lye GJ; Mitrophanous KA; Mukhopadhyay TK
Hum Gene Ther Methods; 2013 Apr; 24(2):125-39. PubMed ID: 23461548
[TBL] [Abstract][Full Text] [Related]
36. Production of Lentiviral Vectors Using a HEK-293 Producer Cell Line and Advanced Perfusion Processing.
Tran MY; Kamen AA
Front Bioeng Biotechnol; 2022; 10():887716. PubMed ID: 35774066
[TBL] [Abstract][Full Text] [Related]
37. Continuous production process of retroviral vector for adoptive T- cell therapy.
Inwood S; Xu H; Black MA; Betenbaugh MJ; Feldman S; Shiloach J
Biochem Eng J; 2018 Apr; 132():145-151. PubMed ID: 29977134
[TBL] [Abstract][Full Text] [Related]
38. Glycoprotein Ibalpha promoter drives megakaryocytic lineage-restricted expression after hematopoietic stem cell transduction using a self-inactivating lentiviral vector.
Lavenu-Bombled C; Izac B; Legrand F; Cambot M; Vigier A; Massé JM; Dubart-Kupperschmitt A
Stem Cells; 2007 Jun; 25(6):1571-7. PubMed ID: 17379771
[TBL] [Abstract][Full Text] [Related]
39. Transduction of human hematopoietic stem cells by lentiviral vectors pseudotyped with the RD114-TR chimeric envelope glycoprotein.
Di Nunzio F; Piovani B; Cosset FL; Mavilio F; Stornaiuolo A
Hum Gene Ther; 2007 Sep; 18(9):811-20. PubMed ID: 17824830
[TBL] [Abstract][Full Text] [Related]
40. Generation of a high-titer packaging cell line for the production of retroviral vectors in suspension and serum-free media.
Ghani K; Cottin S; Kamen A; Caruso M
Gene Ther; 2007 Dec; 14(24):1705-11. PubMed ID: 17928873
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
